ABSTRACT
Introduction
Coronary artery disease (CAD) had been associated with inflammation, hypertension and various diabetic complications. The inflammatory/immune response is modulated by zinc influence on the balance of anti-and pro-inflammatory cytokines (7) . Regulation of intracellular zinc homeostasis is regulated with metallothioneins (MTs) participation (12) . They are metal binding proteins with low molecular weight and high cysteine content (20) . During inflammatory conditions or oxidative stress, MTs transfer zinc to other apoenzymes or apoproteins and activate zinc dependent antioxidant systems or zinc dependent signaling pathways (10, 11) . It has also been shown that MTs play significant role in the pathogenesis of arterial hypertension or diabetes mellitus (2, 3, 11, 19) .
In human, MTs are encoded by a gene family located on 16q13 region and exist with several isoforms-MT1, MT2, MT3 and MT4 (13) . Most widely distributed isoforms of MTs are MT1A and MT2A and they are expressed in all organs (21) . MT3 is found mainly in the brain and is also called neuronal growth inhibitory factor (17, 21) . A little bit is known about MT4 found during the differentiation of stratified squamous epithelia (18, 21) .
Single nucleotide polymorphisms (SNPs) occur in genome at minor allele frequency greater than 1%. It has been found that SNPs could affect the protein structure, changing their amino-acid sequence or interfering with their regulation (5) . Three different SNPs (rs11640851, rs8052394 and rs1610216) in MT genes were shown to be associated with diabetes and its complications (8, 6, 22) . The appearance of two polymorphisms at positions +1245 or +647 in MT1A gene were connected with increased inflammation in patients with diabetes (6) . It has been also shown that MT1A polymorphism (rs8052394) was associated with diabetes type 2 (DM2) together with decreased serum super-oxide dismutase activity (22) . Different results coming from Giacconi et al. (6) No association between this polymorphism and hypertension had been found (8) .
As our previous studied (2, 3) have shown increased MT serum levels in patients with hypertension or diabetes mellitus type I we have selected two polymorphisms in MT genes (+1245 A/G MT1A and -209 A/G MT2A) which can influence the MT expression to be studied in details as associated with developing of coronary artery disease (CAD) and/or diabetes.
Materials and Methods

Population studies
The study population consists of several subjects divided into healthy controls, diabetic patients (type I and type II), and patients with CAD. The control group included 61 healthy volunteers (mean age 55.9±14.1 years), without diabetes and angina symptoms and with normal physical examination and exercise stress test. Diabetic patients' group included 101 subjects without diagnosis of cardiovascular disease (NCVDDP, mean age 52.1± 15.0 years). CAD patients (mean age 60.5± 9.5 years) consist of 142 subjects with stable angina pectoris (SAP) and acute coronary syndrome (ACS). Patients were admitted to the Clinic of Cardiology at University Hospital 'St. Anna', Sofia, Bulgaria. The group of ACS patients involved subjects with unstable angina pectoris and with myocardial infraction without ST elevation. Excluded from the study were patients with surgical intervention or major trauma within the preceding months and all subjects with acute or chronic inflammatory diseases, malignancies, renal insufficiency, and severe liver disease, or on immunosuppressive and antibiotic treatments.
All subjects gave written informed content in accordance with the approval of the institutional Ethics Committees at "St. Anna Hospital" No 54/28.02.2005 and confirmed with the principles outlined in the Declaration of Helsinki (1).
Ultrasonographic examinations
Ultrasonographic examinations were performed with a Fukuda Denshi UF-750 XT, equipped with 7 or 10 MHz transducers, with subjects in the supine position. An ECG signal synchronized the image analysis to the end of diastole. The left and right carotid and femoral arteries were examined. The carotid artery was scanned at the level of the bifurcation with the head turned to the right. The examined region included 30 mm of the common carotid artery, the carotid bulb, and 10 mm each of the internal and external carotid arteries. The femoral artery was examined distally to the inguinal ligament at the bifurcation into the superficial and profound femoral arteries. The area scanned was approximately 30 mm proximal and 10 mm distal to the femoral bifurcation. The regions were scanned with both longitudinal and transverse projections, in order to assess the occurrence of plaques. Three Bmode images from the longitudinal view, as well as a short sequence of real-time images, were recorded. Doppler ultrasound was used for information on blood flow velocity (PSV and PDV), and for vessel identification. Three 'frozen' images were recorded for assessments of intimamedia thickness and lumen diameter. Optimal image projection was considered to be achieved when ultrasound beams were perpendicular to the far vessel wall.
Assessments of intima-media thickness (IMT)
The ultrasonographic images were analyzed with a computerized system, and blind evaluation was made in terms of treatment. Intima-media thickness was defined as the distance from the leading edge of the lumen-intima interface to the leading edge of the media-adventitia interface of the far wall. Intima-media thickness was measured in a 10-mm long segment just proximal to the carotid bulb in the common carotid artery (CCA) and in a 15-mm long segment just proximal to the bifurcation in the femoral artery (CFA). The computer program calculated the minimum, maximum and mean values of intima-media thickness from three separate images.
Genomic DNA extraction
Peripheral blood leucocytes taken from controls and patients were used for genomic DNA extraction by salting out extraction procedure (14) . Genotypes were determined by a Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism Analysis (RFLP) technique.
Molecular analysis of +1245 A/G MT1A and -209 A/G MT2A polymorphisms
Both single nucleotide polymorphisms at +1245 nt position in coding region of human MT1A gene corresponding to A/G transition (Lys51Arg amino acid substitution) and the second one at locus -209 in the promoter region of human MT2A gene corresponding to A/G transition were studied. These SNPs (PubMed References rs8052394, rs1610216) could be found in dbSNP database (http://www.ncbi.nlm.nih.gov/SNP). CAG TG and antisense 5' AAA GAA AAC CAG AGC CAG CA are taken from previous published article (6) . PCR mixture at final volume twenty microliters was composed from genomic DNA samples (100 ng), 800 µM dNTPs, 3mM MgCl 2 , 1x Taq polymerase buffer, 5% of DMSO, 5 pmol of each primer, and 1U of Taq Polymerase (Genet Bio, Korea). Amplification was performed by initial incubation at 94°C for 2 min and the following 30 cycles were at 94°C for 35 sec, 56.4°C for 45 sec, 72°C for 45 sec, with a final extension at 72°C for 3 min. PCR products were digested with 3U Pst I (New England Biolabs, UK) at 37°C for 3 hours. After digestion of the PCR products the 390 bp fragment for AA homozygotes, 199 bp and 191 bp for GG homozygotes and all three fragments for heterozygotes were detected. DNA fragments were separated on 3% agarose gel containing 0.5 µg/ml ethidium bromide and visualized with UV light (DNR BIO-Imaging Systems-MiniBIS PRO 25 mm).
PCR and RFLP reaction conditions for +1245
PCR and RFLP reaction conditions for -209 A/G MT2A polymorphism
The primer sequences for -209 MT2A polymorphism: sense 5' GGC TCA GGT TCG AGT ACA GG and antisense 5' AAG TCA CTT GCG GCT CCA are taken from previous published article (8) .
PCR mixture at final volume twenty microliters was composed from genomic DNA samples (100ng), 500 µM dNTPs, 2 mM MgCl 2 , 1x Taq polymerase buffer, 5% of DMSO, 2.5 pmol of each primer, 1U of Taq Polymerase (Genet Bio, Korea). Amplification was performed by initial incubation at 94°C for 2 min and the following 35 cycles were at 94°C for 35 sec, 62°C for 45 sec, 72°C for 45 sec and final extension at 72°C for 2 min. PCR products were digested with 3U Sma I (New England Biolabs, UK) at 25°C for 3 hours. After digestion of the PCR products of 247 bp fragment for AA homozygotes, 131 bp and 115 bp for GG homozygotes and all three fragments for heterozygotes were registered by separating on 3% agarose gel containing 0.5 µg/ml ethidium bromide and visualized under same conditions mentioned above.
Statistical analysis
The Hardy-Weinberg equilibrium for genotype and allele distribution of +1245 A/G MT1A and -209 A/G MT2A in controls and patients were compared by Chi-square test. One-way ANOVA and Bonferroni post-hoc test were used for comparison of the biochemical data and are presented as mean ± S.D. Chi-square test was used to perform the genotype incidence and Fisher's exact test was used to calculate 95% confidence interval (CI) and odds ratios (OR). Binary logistic regression model was applied to examine whether the polymorphisms +1245 A/G MT1A and -209 A/G MT2A are associated with CAD and/or diabetes developing following adjustment for classical risk factors for cardiovascular complications -hypertension, male sex, family history, obesity, age, smoking, cholesterol and triglyceride levels. The data were considered significant when probability values were less than 0.05. Statistical analyses were carried out with PASW Statistics 18 (IBM, USA).
Multifactor dimensional reduction (MDR, open-source of MDR software package version 2.0 beta 7) analyses were conducted to evaluate genegene and gene-environment interactions (9, 15) .
Results and Discussion
Clinical characteristics of healthy controls and all groups of patients studied are listed in =11.995, p=0.002) for contrast of previously published data, where no differences in genotype and allele frequency for +1245 A/G MT1A polymorphism were observed (6) .
The investigations for the second MT SNPs (-209 A/G MT2A) showed that patients with NCVDDP or CAD had significant increased -209 AG+GG genotype frequencies compared to control subjects with the same genotype ( To clarify the possible role of both +1245 A/G MT1A and -209 A/G MT2A polymorphisms as risk factors for developing of CAD or diabetes we applied binary logistic regression analyses. After adjustment for classical risk factors such as age, sex (male), smoking, obesity, hypertension, family history, cholesterol (over 5.2 mmol/L) and triglyceride levels (over 1.5 mmol/L), we found that AA genotype carriers for +1245 A/G MT1A polymorphism compared to +1245 AG+GG one were significantly associated (OR=4.958; 95% CI=1.488-16.516; p=0.009) with coronary artery disease ( Table 3) while -209 MT2A (AG+GG) genotype carriers compared with AA genotype showed association only with diabetes ( Table 3, OR=7.557; 95% CI=0.918-62.202; p=0.050). The data received from our study showed that both +1245 A/G MT1A and -209 A/G MT2A polymorphisms together with classical risk factors could be used as a tool for additional clarification of the mechanisms involved in pathogenesis of multifactorial diseases such CAD or diabetes. To further evaluate the role of both polymorphisms in these diseases we applied MDR method. It was necessary because the classical logistic regression models are not powerful enough for modeling complex multi-factor interactions (16 MDR analyses for the data set of subjects with diabetes mellitus showed the best interaction model between +1245 A/G MT1A and -209 A/G MT2A together with age over 55 years. This model has highest CVC of 10 and a highest testing accuracy of 73.33% among all possible combinations of factors ( Table 4 , p<0.0001).
The two-and four-locus/factors models had a maximum testing accuracy of 75.11% and 70.29%, and a maximum CVC of 10 and 7 that were significant at p<0.0001 level, as determined empirically by permutation testing. The fourlocus/factors model includes both SNPs +1245 A/G MT1A and -209 A/G MT2A with smoking and cholesterol level higher than 5.2 mmol/L ( Table 4 , p<0.0001). These results showed an association of both MT SNPs together with higher cholesterol and smoking with developing of CAD in patients with diabetes.
An entropy based interaction graphs were established using the most significant variants in the MDR analysis. The interaction graph (Fig. 1A) presents that +1245 A/G MT1A and -209 A/G MT2A polymorphisms have independent effects for CAD developing with 4.03% percent of entropy for +1245 A/G MT1A and 3.67% for -209 A/G MT2A. It was also found that smoking and age, as risk factors for CAD, showed small synergistic effect with 0.38% of entropy.
The +1245 A/G MT1A SNP (3.22%) and -209 A/G MT2A SNP (11.70%) showed strong independent effect for developing of NCVDDP. There were found synergistic effects with 2.44% between age and +1245 A/G MT1A polymorphism and 1.82% between age and hypertension (Fig. 1B) .
It was also observed that +1245 A/G MT1A (5.50%) and -209 A/G MT2A (3.88%) SNPs together with cholesterol over 5.2 mmol/L (6.91%), and smoking (7.36) have main independent effect for developing CAD in patients with diabetes (Fig.  1C) . This entropy model do not presents a clear interaction effect between +1245 A/G MT1A, -209 A/G MT2A SNPs and smoking, while the interaction between +1245 A/G MT1A and higher cholesterol level has the strongest synergistic effect associated with development of the cardio-vascular complications (Fig. 1C) . Thus the entropy analysis identifies these factors and SNPs as the top candidates to be carried forward in future detailed investigations. 
Conclusions
The present examination shows different distribution of +1245 A/G MT1A polymorphism among healthy controls and patients in Bulgarian cohort. It was also found that the single nucleotide polymorphisms +1245 A/G MT1A and -209 A/G MT2A are related with diabetic complications and CAD developing. MDR analyses confirmed that both MT SNPs studied independently or in combination with classical risk factors for atherosclerosis are associated with developing of CAD and/or diabetes.
